病因不明的儿童急性肝衰竭:一项研究研讨会
儿童急性肝衰竭(PALF)约30%病例病因不明,其自发生存率低于其他诊断组、移植率和死亡率更高。美国国立糖尿病、消化和肾脏疾病研究所赞助的单日研讨会汇集临床医生和基础科学家,探讨不确定病因PALF与噬血细胞性淋巴组织细胞增生症(HLH)和巨噬细胞活化综合征(MAS)高炎症状态的相似性,以及骨髓来源窦状内皮祖细胞(sprocs)在肝再生中的作用。结论认为HLH和MAS的治疗试验经验可为PALF研究设计提供参考,限制神经炎症和标准化神经保护方案可能改善完整生存,且需多中心合作和生物样本库管理。
要点
- 约30%的PALF病例缺乏明确病因,其自发生存率更低、移植率和死亡率更高。
- 不确定病因PALF的临床表型与HLH和MAS的高炎症状态有重要相似性。
- 细胞毒性T细胞未能限制或收缩炎症反应可能促进损伤并阻碍肝再生。
核心结论
- HLH和MAS的儿童治疗试验经验可为PALF治疗研究设计提供参考。
- 通过减少全身炎症和标准化神经保护方案限制神经炎症,可能显著改善完整生存。
- PALF为罕见病,研究 effort 必须包括广泛多中心合作和生物样本库标本的谨慎管理。
研究设计与样本
- 美国国立糖尿病、消化和肾脏疾病研究所赞助的单日研讨会,汇集临床医生和基础科学家。
- 研讨会旨在整合相关研究发现,并为新的机制研究和未来治疗试验奠定基础。
主要发现
- 约30%的PALF病例缺乏已识别的肝损伤病因。
- 病因不明的儿童自发生存率低于其他诊断组,移植率和死亡率更高。
- 不确定病因PALF的临床表型与HLH和MAS的高炎症状态有重要相似性。
- 细胞毒性T细胞未能限制或收缩炎症反应可能促进损伤,并导致不支持正常肝再生的局部和全身环境。
- 骨髓来源的窦状内皮祖细胞(sprocs)在肝再生中起重要作用,压倒性全身炎症反应可能抑制骨髓sprocs的动员并减弱肝脏恢复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Pediatric acute liver failure (PALF) is a potentially devastating condition that occurs in previously healthy children of all ages and frequently leads to a rapid clinical deterioration. An identified cause for liver injury is lacking in approximately 30% of cases. Children with undetermined diagnosis have lower spontaneous survival and higher rates of transplantation and death than other diagnostic groups. A single-day workshop sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases brought together clinicians and basic scientists to integrate aligned research findings and develop a foundation for new mechanistic studies and future treatment trials. The clinical phenotype of indeterminate PALF shares important similarities to the hyperinflammatory state characteristic of hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS). A failure of cytotoxic T cells to limit or contract inflammatory responses may propagate injury and lead to a local and systemic milieu that does not support normal hepatic regeneration. Evidence was presented that bone marrow (BM)-derived Sinusoidal endothelial cell PROgenitor Cells (sprocs) play a vital role in hepatic regeneration. Overwhelming systemic inflammatory responses may suppress mobilization of BM sprocs and dampen hepatic recovery. CONCLUSION: Experience gained through treatment trials of HLH and MAS in childhood may inform study design for therapy of PALF. Successful approaches to limiting neuroinflammation through reduction of systemic inflammation and standardized neuroprotection protocols that limit glial injury could significantly improve intact survival. Finally, given that PALF is a rare disease, investigative efforts must include broad multicenter collaboration and careful stewardship of biorepository specimens. (Hepatology 2017;65:1026-1037).
引用
- Alonso EM, Horslen SP, Behrens EM, et al. Pediatric acute liver failure of undetermined cause: A research workshop. Hepatology. 2017. PMID: 27862115. doi:10.1002/hep.28944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。